Trials / Completed
CompletedNCT01601314
Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Sara Varea · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the relationship between magnesium sulphate administration and levels of S100B protein in serum of patients undergoing supratentorial brain parenchymal resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulfate | At the beginning of the neurosurgery, the subjects are going to receive one 4gr bolus in Sodium Chloride 100 mL, lasting 20 minutes, intravenously. After that, a intravenously perfusion of Magnesium Sulfate 20 gr, in Sodium Chloride 1000 mL, lasting 24 hours, will be started. |
| OTHER | Sodium Chloride | At the beginning of the neurosurgery, the subjects are going to receive a bolus of Sodium Chloride 100 mL, lasting 20 minutes, intravenously. After that, a intravenously perfusion of Sodium Chloride 1000 mL, lasting 24 hours, will be started. |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2012-05-18
- Last updated
- 2018-01-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01601314. Inclusion in this directory is not an endorsement.